Day One Biopharmaceuticals Inc. (DAWN) Business Metric Overview - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Day One Biopharmaceutical...

    NASDAQ: DAWN · Real-Time Price · USD
    6.77
    0.09 (1.35%)
    At close: Sep 26, 2025, 3:59 PM
    6.97
    2.95%
    After-hours: Sep 26, 2025, 07:49 PM EDT

    Day One Biopharmaceuticals Revenue Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024
    License Revenue 346K 258K 253K 73.69M 8.19M
    License Revenue Growth +34.11% +1.98% -99.66% +799.55% n/a
    Product Revenue 33.56M 30.5M 28.95M 20.07M n/a
    Product Revenue Growth +10.03% +5.35% +44.27% n/a n/a

    Operating Expense Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
    Selling, General, and Administrative Revenue 28.97M 29.32M 29.73M 28.97M 30.19M 26.44M 22.17M 18.27M 17.07M 18.03M 16.72M 17.66M 14.16M 12.74M 29.16M 9.39M 5.53M 3.45M 1.98M 1.02M 872K 808K
    Selling, General, and Administrative Revenue Growth -1.22% -1.38% +2.63% -4.02% +14.16% +19.27% +21.31% +7.05% -5.30% +7.80% -5.33% +24.75% +11.09% -56.29% +210.47% +69.99% +59.96% +74.53% +93.26% +17.43% +7.92% n/a
    Research and Development Revenue 36.15M 39.62M 61.82M 33.56M 92.11M 40.21M 37.35M 33.16M 32.18M 27.83M 26.02M 22.04M 22.56M 15M 43.58M 9.85M 9.91M 12.63M 4.17M 2.54M 1.44M 961K
    Research and Development Revenue Growth -8.76% -35.92% +84.20% -63.56% +129.06% +7.66% +12.62% +3.05% +15.65% +6.95% +18.08% -2.33% +50.37% -65.58% +342.52% -0.66% -21.52% +203.29% +64.17% +76.55% +49.53% n/a

    Add to Watchlist